Global Pharmaceuticals & Biotech Blue chip stocks

Illumina

Market Cap: US$12.4b

Provides sequencing- and array-based solutions for genetic and genomic analysis in the Americas, Europe, Greater China, the Asia Pacific, the Middle East, and Africa.

Alnylam Pharmaceuticals

Market Cap: US$35.7b

Alnylam Pharmaceuticals, Inc. discovers, develops, and commercializes therapeutics based on ribonucleic acid interference.

Exact Sciences

Market Cap: US$10.1b

Provides cancer screening and diagnostic test products in the United States and internationally.

Innovent Biologics

Market Cap: HK$89.5b

A biopharmaceutical company, develops, manufactures and commercializes monoclonal antibodies and other drug assets in the fields of oncology, ophthalmology, autoimmune, and cardiovascular and metabolic diseases in China.

Vertex Pharmaceuticals

Market Cap: US$128.6b

A biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis (CF).

Akeso

Market Cap: HK$77.8b

A biopharmaceutical company, engages in the research, development, manufacturing, and commercialization of antibody drugs.

Natera

Market Cap: US$21.4b

A diagnostics company, provides molecular testing services worldwide.

Revvity

Market Cap: US$11.2b

Provides health sciences solutions, technologies, and services worldwide.

Viatris

Market Cap: US$10.3b

Operates as a healthcare company in North America, Europe, China, Taiwan, Hong Kong, Japan, Australia, New Zealand, rest of Asia, Africa, Latin America, and the Middle East.

Neurocrine Biosciences

Market Cap: US$10.9b

Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, neuroendocrine, and neuropsychiatric disorders in the United States and internationally.

BeiGene

Market Cap: US$27.4b

An oncology company, engages in discovering and developing various treatments for cancer patients in the United States, China, Europe, and internationally.

WuXi Biologics (Cayman)

Market Cap: HK$94.4b

An investment holding company, provides end-to-end solutions and services for biologics discovery, development, and manufacturing for biologics industry in the People’s Republic of China, North America, Europe, Singapore, Japan, South Korea, and Australia.

Eurofins Scientific

Market Cap: €10.4b

Provides various analytical testing and laboratory services worldwide.

ALTEOGEN

Market Cap: ₩19.0t

A bio company, focuses on developing long-acting biobetters, proprietary antibody-drug conjugates, and antibody biosimilars.

Swedish Orphan Biovitrum

Market Cap: SEK 102.6b

A biopharma company, provides medicines in the areas of haematology, immunology, and specialty care in Europe, North America, the Middle East, Asia, and Australia.

AbbVie

Market Cap: US$346.8b

A research-based biopharmaceutical company, engages in the research and development, manufacture, commercialization, and sale of medicines and therapies worldwide.

UCB

Market Cap: €31.0b

A biopharmaceutical company, develops products and solutions for people with neurology and immunology diseases worldwide.

argenx

Market Cap: €34.6b

A commercial-stage biopharma company, develops various therapies for the treatment of autoimmune diseases in the United States, Japan, China, the Netherlands, and internationally.

Eli Lilly

Market Cap: US$737.5b

Eli Lilly and Company discovers, develops, and markets human pharmaceuticals in the United States, Europe, China, Japan, and internationally.

GSK

Market Cap: UK£58.7b

Engages in the research, development, and manufacture of vaccines, and specialty and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally.

AstraZeneca

Market Cap: UK£165.9b

A biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines.

Recordati Industria Chimica e Farmaceutica

Market Cap: €11.0b

Researches, develops, produces, and sells pharmaceuticals in Italy, the United States, Spain, France, Germany, Russia, Ukraine, Turkey, Portugal, North Africa, and internationally.

Roche Holding

Market Cap: CHF 217.8b

Engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and New Zealand.

Incyte

Market Cap: US$12.0b

A biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutics in the United States, Europe, Canada, and Japan.

Genmab

Market Cap: DKK 86.7b

A biotechnology company, develops antibody-based products and product candidates for the treatment of cancer and other diseases in Denmark.

Novo Nordisk

Market Cap: DKK 2.0t

Engages in the research and development, manufacture, and distribution of pharmaceutical products in Europe, the Middle East, Africa, Mainland China, Hong Kong, Taiwan, North America, and internationally.

Exelixis

Market Cap: US$11.0b

An oncology company, focuses on the discovery, development, and commercialization of new medicines for difficult-to-treat cancers in the United States.

CSL

Market Cap: AU$121.3b

Researches, develops, manufactures, markets, and distributes biopharmaceutical and vaccines in Australia, the United States, Germany, the United Kingdom, Switzerland, China, Hong Kong, and internationally.

Daiichi Sankyo Company

Market Cap: JP¥6.9t

Manufactures and sells pharmaceutical products in Japan, North America, Europe, and internationally.